Use of a renal-specific oral supplement by haemodialysis patients with low protein intake does not increase the need for phosphate binders and may prevent a decline in nutritional status and quality of life
Authors:
- Denis FouqueDFDenis Fouque
- the Renilon Multicentre Trial Study GroupTGthe Renilon Multicentre Trial Study Group
Open Access
- 3 April 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 23 (9) , 2902-2910
Abstract
Background. Protein-energy wasting is a frequent and debilitating condition in maintenance dialysis. We randomly tested if an energy-dense, phosphate-restricted, renal-specific oral supplement could maintain adequate nutritional intake and prevent malnutrition in maintenance haemodialysis patients with insufficient intake. Methods. Eighty-six patients were assigned to a standard care (CTRL) group or were prescribed two 125-ml packs of Renilon 7.5® daily for 3 months (SUPP). Dietary intake, serum (S) albumin, prealbumin, protein nitrogen appearance (nPNA), C-reactive protein, subjective global assessment (SGA) and quality of life (QOL) were recorded at baseline and after 3 months. Results. While intention to treat analysis (ITT) did not reveal strong statistically significant changes in dietary intake between groups, per protocol (PP) analysis showed that the SUPP group increased protein ( P < 0.01) and energy ( P < 0.01) intakes. In contrast, protein and energy intakes further deteriorated in the CTRL group (PP). Although there was no difference in serum albumin and prealbumin changes between groups, in the total population serum albumin and prealbumin changes were positively associated with the increment in protein intake ( r = 0.29, P = 0.01 and r = 0.27, P = 0.02, respectively). The SUPP group did not increase phosphate intake, phosphataemia remained unaffected, and the use of phosphate binders remained stable or decreased. The SUPP group exhibited improved SGA and QOL ( P < 0.05). Conclusion. This study shows that providing maintenance haemodialysis patients with insufficient intake with a renal-specific oral supplement may prevent deterioration in nutritional indices and QOL without increasing the need for phosphate binders.Keywords
This publication has 47 references indexed in Scilit:
- Intradialytic Parenteral Nutrition Does Not Improve Survival in Malnourished Hemodialysis PatientsJournal of the American Society of Nephrology, 2007
- Nutritional Parameters and Mortality in Incident Hemodialysis PatientsJournal of Renal Nutrition, 2006
- POOR NUTRITIONAL STATUS AND INFLAMMATION: Protein and Energy: Recommended Intake and Nutrient Supplementation in Chronic Dialysis PatientsSeminars in Dialysis, 2004
- Subjective Global Assessment in chronic kidney disease: A reviewJournal of Renal Nutrition, 2004
- Stroke following Chiropractic Manipulation: A Genuine RiskCerebrovascular Diseases, 2003
- Oral supplementation of branched‐chain amino acid improves nutritional status in elderly patients on chronic haemodialysisNephrology Dialysis Transplantation, 2001
- The hemodialysis pilot study: Nutrition program and participant characteristics at baselineJournal of Renal Nutrition, 1998
- The impact of malnutrition in morbidity and mortality in stable haemodialysis patientsNephrology Dialysis Transplantation, 1997
- A role for oral nutrition supplements in the malnutrition of renal diseaseJournal of Renal Nutrition, 1996
- The MOS 36-Item Short-Form Health Survey (SF-36)Medical Care, 1993